Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6774
Gene Symbol: STAT3
STAT3
0.700 Biomarker disease MGD
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.600 Biomarker disease MGD
Entrez Id: 26525
Gene Symbol: IL36RN
IL36RN
0.380 Biomarker disease CTD_human
Entrez Id: 130340
Gene Symbol: AP1S3
AP1S3
0.300 Biomarker disease CTD_human
Entrez Id: 10093
Gene Symbol: ARPC4
ARPC4
0.200 Biomarker disease MGD
Entrez Id: 9517
Gene Symbol: SPTLC2
SPTLC2
0.200 Biomarker disease MGD
Entrez Id: 3240
Gene Symbol: HP
HP
0.030 GeneticVariation disease BEFREE 4) Patients with late onset of psoriasis showed an increase in the blood group (Fy(a+bb-) and a decrease in the haptoglobin type 2-2. 71831 1977
Entrez Id: 5858
Gene Symbol: PZP
PZP
0.010 AlteredExpression disease BEFREE Increased serum levels of the pregnancy zone protein in psoriasis. 73306 1977
Entrez Id: 3105
Gene Symbol: HLA-A
HLA-A
0.100 Biomarker disease BEFREE Sixty-one patients in the Dundee area suffering from psoriasis were typed for HLA-A and HLA-B antigens. 91225 1979
Entrez Id: 3107
Gene Symbol: HLA-C
HLA-C
0.400 Biomarker disease BEFREE HLA C and D antigens associated with psoriasis. 147699 1978
Entrez Id: 3108
Gene Symbol: HLA-DMA
HLA-DMA
0.010 Biomarker disease BEFREE The frequency of two newly defined HLA antigens, HLA CT7 and DMA, was found to be greatly increased in patients with psoriasis. 147699 1978
Entrez Id: 6261
Gene Symbol: RYR1
RYR1
0.010 GeneticVariation disease BEFREE The present family investigation has shown that genes within the MHS are mainly responsible for the development of psoriasis or psoriasis-associated arthritic lesions (peripheral arthritis and sacroiliitis). 968898 1976
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.400 AlteredExpression disease BEFREE Interleukin-6 in psoriasis: expression and mitogenicity studies. 1294020 1992
Entrez Id: 5947
Gene Symbol: RBP1
RBP1
0.020 Biomarker disease BEFREE These results indicate a switch to the overexpression of CRABP-II mRNA in psoriasis which induces high levels of the protein mainly in LPS; these observations may be relevant to the pathophysiology and therapy of psoriasis as CRABP-I and -II have different ligand-binding affinities. 1335801 1992
Entrez Id: 1381
Gene Symbol: CRABP1
CRABP1
0.010 Biomarker disease BEFREE These results indicate a switch to the overexpression of CRABP-II mRNA in psoriasis which induces high levels of the protein mainly in LPS; these observations may be relevant to the pathophysiology and therapy of psoriasis as CRABP-I and -II have different ligand-binding affinities. 1335801 1992
Entrez Id: 7051
Gene Symbol: TGM1
TGM1
0.030 AlteredExpression disease BEFREE Precocious expression of TGase K protein occurs in psoriasis, and quantitative Northern blot analysis of TGase K mRNA from normal and involved epidermal biopsies from psoriasis patients suggests that TGase K mRNA levels are increased in psoriatic lesions. 1351505 1992
Entrez Id: 2806
Gene Symbol: GOT2
GOT2
0.050 Biomarker disease BEFREE Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. 1512466 1992
Entrez Id: 6898
Gene Symbol: TAT
TAT
0.010 GeneticVariation disease BEFREE Our finding suggests that this activity of the tat gene may be responsible for the epidermal hyperplasia that accompanies psoriasis and precedes the development of squamous cell and basal cell carcinomas in AIDS patients. 1630815 1992
Entrez Id: 2162
Gene Symbol: F13A1
F13A1
0.010 Biomarker disease BEFREE Although previous attempts to demonstrate viral sequences in psoriasis and KS lesions have been unsuccessful, in situ hybridization with confocal microscopy has shown the presence of HIV RNA transcripts predominantly within CD4+, Factor XIIIa positive dermal dendrocytes. 1676036 1991
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.370 Biomarker disease BEFREE Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways. 1677800 1991
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.060 Biomarker disease BEFREE Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways. 1677800 1991
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.010 GeneticVariation disease BEFREE A polymorphism of the switch region of the mu IgH gene (S mu) is associated with arthritis in English patients with psoriasis. 1684125 1991
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.400 Biomarker disease BEFREE Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. 1702929 1991
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.370 Biomarker disease BEFREE To begin dissecting the cytokine network involved in the pathophysiology of psoriasis, the location, in both epidermal and dermal compartments, of tumor necrosis factor-alpha, interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha at the protein and/or mRNA levels were identified. 1702929 1991
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.100 Biomarker disease BEFREE Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. 1702929 1991